Skip to main content

Table 1 Characteristics and outcomes of patients who underwent robot-assisted laparoscopic prostatectomy

From: Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: a retrospective study

Variable All patients (N = 1430)
Age, year 66.3 (7.2)
Body mass index, kg m−2 24.7 (5.1)
ASA physical status
 1 486 (34%)
 2 843 (59%)
  ≥ 3 101 (7.1%)
Charlson Comorbidity Index score 4.73 (1.22)
 2 21 (1.5%)
 3 165 (11.5%)
 4 456 (31.9%)
 5 479 (33.5%)
 6 202 (14.1%)
  ≥ 7 107 (7.7%)
Anesthesia related factors
 NMB reversal agents (sugammadex vs. neostigmine) 924 (64.6%) vs. 506 (35.4%)
 Intraoperative remifentanil dose, per 100 mcg 9.7 (4.6)
 Intraoperative rocuronium dose, per 10 mg 8.1 (2.2)
 Intraoperative estimated blood loss, mL 166.1 (138.2)
 Duration of anesthesia, h 4.0 (0.8)
Outcomes
 Length of hospital stay, days 7.8 (2.1)
 Readmission within 30 days 29 (2%)
 Unplanned readmission within 30 days due to surgical problem 18 (1.3%)
 Cause of unplanned readmission within 30 days due to surgical problems
  Voiding difficulty 10/18 (56%)
  Intrapelvic fluid collection 4/18 (22%)
  Ileus 2/18 (11%)
Charge  
 Total charges for postoperative hospitalization, United States dollars 11,034 (1942)
 Net charges for postoperative hospitalization, United States dollars 2918 (1271)
 Charges for anesthesia, United States dollars 344 (78)
  1. ASA American Society of Anesthesiologists, NMB Neuromuscular blockade
  2. Presented as n (%) or mean (standard deviation) or median (interquartile range)